186 / 232
References
[1]
I. Sultan, C. Rodriguez-Galindo, S. Al-Sharabati, M. Guzzo, M. Casanova,
A. Ferrari, Salivary gland carcinomas in children and adolescents: a
population-based study, with comparison to adult cases, Head Neck 33 (2011)
1476
e
1481
.
[2]
C.M. Eneroth, Incidence and prognosis of salivary-gland tumours at different
sites. A study of parotid, submandibular and palatal tumours in 2632 patients,
Acta Otolaryngol. Suppl. 263 (1969) 174
e
178
.
[3]
L.J. Orvidas, J.L. Kasperbauer, J.E. Lewis, K.D. Olsen, T.G. Lesnick, Pediatric pa-
rotid masses, Arch. Otolaryngol. Head. Neck Surg. 126 (2000) 177
e
184
.
[4]
M. Ellies, R. Laskawi, Diseases of the salivary glands in infants and adolescents,
Head Face Med. 6 (2010) 1
.
[5]
D.E. Schuller, B.F. McCabe, Salivary gland neoplasms in children, Otolaryngol.
Clin. North Am. 10 (1977) 399
e
412
.
[6]
E.B. Castro, A.G. Huvos, E.W. Strong, F.W. Foote Jr., Tumors of the major sali-
vary glands in children, Cancer 29 (1972) 312
e
317
.
[7]
M.E. Kupferman, G.O. de la Garza, A.A. Santillan, et al., Outcomes of pediatric
patients with malignancies of the major salivary glands, Ann. Surg. Oncol. 17
(2010) 3301
e
3307
.
[8]
C.H. Terhaard, H. Lubsen, I. Van der Tweel, et al., Salivary gland carcinoma:
independent prognostic factors for locoregional control, distant metastases,
and overall survival: results of the Dutch head and neck oncology cooperative
group, Head Neck 26 (2004) 681
e
692 discussion 692
e
683
.
[9]
R.H. Spiro, J. Armstrong, L. Harrison, N.L. Geller, S.Y. Lin, E.W. Strong, Carci-
noma of major salivary glands. Recent trends, Arch. Otolaryngol. Head Neck
Surg. 115 (1989) 316
e
321
.
[10]
M. Guzzo, A. Ferrari, I. Marcon, et al., Salivary gland neoplasms in children: the
experience of the Istituto Nazionale Tumori of Milan, Pediatr. Blood Cancer 47
(2006) 806
e
810
.
[11]
A.H. Shikhani, M.E. Johns, Tumors of the major salivary glands in children,
Head Neck Surg. 10 (1988) 257
e
263
.
[12]
Q.G. Fang, S. Shi, X. Zhang, M. Li, F.Y. Liu, C.F. Sun, Long term quality of life in
pediatric patients surviving parotid tumors, Int. J. Pediatr. Otorhinolaryngol.
78 (2014) 235
e
237
.
[13]
C. Galer, A.A. Santillan, D. Chelius, et al., Minor salivary gland malignancies in
the pediatric population, Head Neck 34 (2012) 1648
e
1651
.
(
continued
)
Pt# T stage, pathology
Initial treatment
Time to recurrence
(months)
Recurrence treatment
Outcome Length of follow up
(years)
1. Enucleation
(OSH)
2. TP
10 Tx low grade MEC
Enucleation (OSH) 3
TP
Alive
NED
17.7
11 T2 intermediate grade MEC Enucleation (OSH) 8
1. TP with FN sacri
fi
ce (OSH).
2. Multiply recurrent. Treated with RP, Radical ND, radiation
and chemotherapy
DOD 3.1
12 T1 low grade acinic cell
Enucleation (OSH) 18.7
1. Enucleation (OSH).
2. Recurred again and treated with TP
Alive
NED
45.8
13 T4 high grade synovial cell
sarcoma
SMG excision
7.2
Revision SMG excision
Alive
NED
4.7
14 T1 low grade MEC
1. Enucleation
2. TP
540
RP, chemotherapy, radiation
Alive
NED
51.5
MEC: Mucoepidermoid carcinoma, ECS: extracapsular spread, OSH: outside hospital, FN rsxn: facial nerve resection, SP: super
fi
cial parotidectomy, TP: total parotidectomy; RP:
revision parotidectomy, SMG: submandibular gland, NED: no evidence of disease, DOD: dead of disease.
C.C. Cockerill et al. / International Journal of Pediatric Otorhinolaryngology 88 (2016) 1
e
6
164